SLT for Glaucoma with Dr. Nate Lighthizer

Roei Shoustak

In an interactive webinar, Dr. Nate Lighthizer discusses Lumenis SLT’s advantages for glaucoma patients and referral decisions for this trusted laser treatment.

SLT – Mechanism of Action


Brian Francis, MD – from the University of Southern California of Los Angeles and the Doheny Eye Institute was one of the early adopters of the Selective Laser Trabeculoplasty (SLT) technology – a micro-incisional glaucoma surgical procedure.

Improving Glaucoma Patient Compliance with Selective Laser Trabeculoplasty (SLT)


The value of SLT in a private practice setting, SLT as primary or adjunctive therapy, Reducing or replacing glaucoma medications, The benefits of combining SLT with mono-therapy, Detecting non-adherence with glaucoma therapy, Helping patients cope with the high cost of medications
Duration: 54 mins